4.7 Article

Shexiang Baoxin Pill treats acute myocardial infarction by promoting angiogenesis via GDF15-TRPV4 signaling

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Functional role of coupling the endothelial TRPV4 and KCa3.1 channels in regulating coronary vascular tone

Aiqin Mao et al.

Summary: A high-fat diet leads to dysregulated pathways in coronary artery endothelial cells and increases the risk of coronary artery diseases. The coupling between TRPV4 and K(Ca)3.1 channels plays an important role in regulating coronary vascular tone. Folic acid can repair the uncoupled channels and improve coronary arterial function.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Article Peripheral Vascular Disease

Vascular Smooth Muscle TRPV4 (Transient Receptor Potential Vanilloid Family Member 4) Channels Regulate Vasoconstriction and Blood Pressure in Obesity

Yifei Zhu et al.

Summary: Smooth muscle cell TRPV4 plays a significant role in vascular contraction and blood pressure regulation, and its expression level may be associated with obesity. The study found that TRPV4(SMC) has different effects on vasomotor tone regulation compared to endothelial TRPV4, and the loss of TRPV4(SMC) can protect obese mice from vasoconstriction and hypertension.

HYPERTENSION (2023)

Article Multidisciplinary Sciences

Structure of human TRPV4 in complex with GTPase RhoA

Kirill D. Nadezhdin et al.

Summary: Nadezhdin et al. present structures of human TRPV4 in complex with the GTPase RhoA, revealing the mechanisms of channel activation, inhibition, and disease-causing mutations. TRPV4 is a polymodal cellular sensor involved in various physiological processes and diseases. The study demonstrates the interaction between TRPV4 and RhoA, identifies the binding sites of agonist 4α-PDD and inhibitor HC-067047, and provides insights into the activation and inhibition of TRPV4, laying the foundation for the development of therapeutics for TRPV4-related diseases.

NATURE COMMUNICATIONS (2023)

Article Pharmacology & Pharmacy

Single-nucleus ribonucleic acid-sequencing and spatial transcriptomics reveal the cardioprotection of Shexiang Baoxin Pill (SBP) in mice with myocardial ischemia-reperfusion injury

Wenyong Lin et al.

Summary: The mechanism of action of Shexiang Baoxin Pill (SBP) in treating cardiovascular diseases, particularly myocardial ischemia-reperfusion (I/R) injury, remains unclear. This study used heart single-nucleus and spatial RNA sequencing to explore the possible mechanism of SBP in I/R injury. Results showed that SBP improves cardiac contractility, reduces endocardial cell injury, promotes endocardial-mediated angiogenesis, and inhibits fibroblast proliferation, thereby providing cardioprotection against I/R injury.

FRONTIERS IN PHARMACOLOGY (2023)

Article Medicine, General & Internal

Effectiveness and safety of Shexiang Baoxin Pill (MUSKARDIA) in patients with stable coronary artery disease and concomitant diabetes mellitus: a subgroup analysis of a randomized clinical trial

Jingmin Zhou et al.

Summary: This study was a subgroup analysis of a multicenter, randomized, placebo-controlled phase IV trial, aiming to evaluate the benefit of MUSKARDIA on patients with stable coronary artery disease and diabetes mellitus. The results showed that MUSKARDIA could reduce the risk of major adverse cardiovascular events, especially for patients with uncontrolled diabetes.

CHINESE MEDICAL JOURNAL (2023)

Review Cardiac & Cardiovascular Systems

Contemporary Issues in Chronic Total Occlusion Percutaneous Coronary Intervention

Lorenzo Azzalini et al.

Summary: Remarkable progress has been made in chronic total occlusion (CTO) percutaneous coronary intervention (PCI) in recent years, including improvements in technical aspects, imaging, and complication management. Global collaboration has resulted in consensus on terms, indications, and clinical trial design principles, as well as the development of global consensus documents. Advances in pre-procedural and intraprocedural imaging, along with novel techniques and structured CTO crossing and complication management algorithms, have enabled a systematic and stepwise approach to this challenging intervention.

JACC-CARDIOVASCULAR INTERVENTIONS (2022)

Article Cardiac & Cardiovascular Systems

Novel Smooth Muscle Ca2+-Signaling Nanodomains in Blood Pressure Regulation

Yen-Lin Chen et al.

Summary: This study demonstrates the role of TRPV4(SMC) channels in blood pressure regulation, showing that their activity increases resting blood pressure in normal mice. The study also reveals the opposite effects of α1AR-TRPV4(SMC) signaling and intraluminal pressure-TRPV4(SMC)-BK channel signaling on blood pressure. In hypertension, constrictor α1AR-PKCα-TRPV4 signaling is upregulated, while dilator pressure-TRPV4-BK channel signaling is disrupted, leading to increased vasoconstriction and elevated blood pressure.

CIRCULATION (2022)

Review Pharmacology & Pharmacy

Efficacy and safety of Shexiang Baoxin Pill for stable coronary artery disease: A systematic review and meta-analysis of 42 randomized controlled trials

Jingjing Wei et al.

Summary: This study conducted a meta-analysis to verify the therapeutic effect and safety of Shexiang Baoxin Pill (SBP) on stable coronary artery disease (SCAD). The results demonstrated that the combination therapy of SBP with conventional western medicine (CWM) was more effective in reducing major adverse cardiovascular events and improving symptoms and indicators related to angina. The evidence also showed improvements in blood lipid level and left ventricular ejection fraction after SBP treatment.

FRONTIERS IN PHARMACOLOGY (2022)

Article Biology

Functional coupling between TRPV4 channel and TMEM16F modulates human trophoblast fusion

Yang Zhang et al.

Summary: In this study, the authors demonstrate that the calcium channel TRPV4 plays a critical role in the activation of TMEM16F during cell fusion in trophoblasts. They show that TRPV4 activation leads to TMEM16F activation and subsequent trophoblast syncytialization, providing new insights into the physiological mechanisms of cell fusion.

ELIFE (2022)

Article Multidisciplinary Sciences

Extracellular fluid viscosity enhances cell migration and cancer dissemination

Kaustav Bera et al.

Summary: Cells can respond to changes in extracellular fluid viscosity, and higher viscosity can increase cell motility and dissemination. This is achieved through the formation of a dense actin network and the activation of specific signaling pathways. Additionally, cancer cells exposed to high viscosity can acquire mechanical memory and enhance migration and metastasis through transcriptional control.

NATURE (2022)

Article Plant Sciences

Shexiang Baoxin Pill attenuates myocardial ischemia/reperfusion injury by activating autophagy via modulating the ceRNA-Map3k8 pathway

Yong-Wei Yu et al.

Summary: This study found that Shexiang Baoxin Pill (SBP) can inhibit pyroptosis and oxidative stress, and protect against myocardial ischemia/reperfusion injury. Additionally, it inhibits pyroptosis and improves hypoxia/reoxygenation injury by promoting autophagosome generation and accelerating autophagic flux. SBP interferes with autophagy through the interaction between mmu_circ_0005874/mmu-miR-543-3p/Map3k8.

PHYTOMEDICINE (2022)

Article Ophthalmology

Retinal TRP channels: Cell-type-specific regulators of retinal homeostasis and multimodal integration

David Križaj et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2022)

Article Cardiac & Cardiovascular Systems

Shexiang Baoxin Pills Inhibited Proliferation and Migration of Human Coronary Artery Smooth Muscle Cells via PI3K/AKT/mTOR Pathway

Lei Hua et al.

Summary: This study demonstrated that SBP significantly inhibits the proliferation and migration of HCASMCs, and network pharmacology revealed 11 candidate targets. Molecular docking and Western blot assay validated the activation of targets STAT3 and MAPK14 in association with the inhibition of HCASMCs, as well as the inhibition of the PI3K/AKT/mTOR pathway in HCASMCs stimulated by ox-LDL by SBP.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Medicine, General & Internal

Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial

Jun-Bo Ge et al.

Summary: The study aimed to determine the effects of MUSKARDIA in stable CAD patients. The results showed that as an add-on to optimal medical therapy, MUSKARDIA significantly reduced angina frequency and showed a trend towards reducing major adverse cardiovascular events in stable CAD patients, with similar rates of adverse events between the MUSKARDIA and placebo groups.

CHINESE MEDICAL JOURNAL (2021)

Review Biochemistry & Molecular Biology

Growth differentiation factor-15 and its role in diabetes and cardiovascular disease

Adrian C. Eddy et al.

Summary: GDF-15 is often elevated in cardiovascular disease and diabetes, making it a potential biomarker for these conditions, while also playing a protective role. This review focuses on the potential functions of GDF-15 in regulating metabolism, insulin sensitivity, and the cardiovascular system through signaling pathways.

CYTOKINE & GROWTH FACTOR REVIEWS (2021)

Article Cardiac & Cardiovascular Systems

Shexiang Baoxin Pill Attenuates Ischemic Injury by Promoting Angiogenesis by Activation of Aldehyde Dehydrogenase 2

Jingjing Hu et al.

Summary: The study showed that SBP protects against ischemic injury in lower limbs through the ALDH2-dependent pathway, and its protective mechanism in cardiovascular microvascular endothelial cells is partly mediated through the ALDH2/AKT/mammalian target of rapamycin pathways.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2021)

Article Medicine, General & Internal

Efficacy and safety of Shexiang Baoxin Pill combined with Western medicine in the treatment of acute myocardial infarction A single-center, double-blind, randomized controlled trial

Yan Yang et al.

Summary: This study aims to evaluate the clinical efficacy and safety of Shexiang Baoxin Pill combined with Western medicine in the treatment of acute myocardial infarction, with observed indexes including total effective rate of improvement of cardiac function, left ventricular ejection fraction, nitric oxide level, among others. The results will provide clinical basis for this combined therapy.

MEDICINE (2021)

Article Biochemistry & Molecular Biology

Activation of the mechanosensitive Ca2+ channel TRPV4 induces endothelial barrier permeability via the disruption of mitochondrial bioenergetics

Qing Lu et al.

Summary: Mechanical ventilation is crucial in treating acute respiratory distress syndrome, but it can also cause ventilator-induced lung injury. Research suggests that TRPV4 activation may disrupt pulmonary vascular barrier through eNOS uncoupling, and interventions targeting eNOS could potentially prevent VILI.

REDOX BIOLOGY (2021)

Article Peripheral Vascular Disease

Endothelial TRPV4 channels prevent tumor growth and metastasis via modulation of tumor angiogenesis and vascular integrity

Anantha K. Kanugula et al.

Summary: TRPV4 plays a critical role in tumor growth, angiogenesis, and metastasis, with endothelial TRPV4 being a key modulator of vascular integrity and tumor angiogenesis. Deletion of TRPV4 promotes tumor angiogenesis, growth, and metastasis.

ANGIOGENESIS (2021)

Review Cardiac & Cardiovascular Systems

Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association

Timothy D. Henry et al.

Summary: CS remains the leading cause of mortality in patients with acute myocardial infarction, and early revascularization has shown survival benefit in treating CS patients. A recent classification scheme and scientific statement have recommended the establishment of CS centers with standardized protocols for diagnosis and management.

CIRCULATION (2021)

Article Plant Sciences

Quantitative proteomics reveals Shexiang Baoxin Pill exerts cardioprotective effects by preserving energy metabolism in a rat model of myocardial infarction

Feng Yu et al.

Summary: The study demonstrates that Shexiang Baoxin Pill (SBP) provides significant cardioprotective effects in myocardial infarction (MI) rats by preserving energy metabolism in cardiac tissue, particularly involving proteins related to cellular mitochondrial energy processes such as fatty acid beta-oxidation and aerobic respiration.

JOURNAL OF ETHNOPHARMACOLOGY (2021)

Review Cell Biology

Shexiang Baoxin Pill for Acute Myocardial Infarction: Clinical Evidence and Molecular Mechanism of Antioxidative Stress

Jianbo Guo et al.

Summary: The study evaluated the effectiveness and safety of Shexiang Baoxin Pill (SBP) for acute myocardial infarction (AMI) and found that SBP was effective in improving clinical symptoms, cardiac function, oxidative stress, and inflammatory responses. Laboratory findings confirmed that SBP can enhance the activity of endothelial nitric oxide synthase and have adjunctive effects on AMI through antioxidative stress mechanisms.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Review Cardiac & Cardiovascular Systems

Myocardial stunning and hibernation revisited

Gerd Heusch

Summary: This review summarizes the pathophysiology of myocardial stunning and hibernation, emphasizing potential treatments and clinical implications. It is important to have a better understanding of these characteristic reperfusion phenomena to determine the indication for revascularization more precisely and its consequences in patients with chronic coronary syndromes.

NATURE REVIEWS CARDIOLOGY (2021)

Article Pharmacology & Pharmacy

Combination of Ginsenosides Rb2 and Rg3 Promotes Angiogenic Phenotype of Human Endothelial Cells via PI3K/Akt and MAPK/ERK Pathways

Ran Joo Choi et al.

Summary: Shexiang Baoxin Pill (SBP) promotes angiogenesis through the synergistic effects of ginsenosides Rb2 and Rg3, which activate the PI3K/Akt and MAPK/ERK signaling pathways to enhance endothelial cell proliferation and tube formation. The study also suggests that SBP, via Rb2 and Rg3, utilizes the CXCR1/2 CXCL8 (IL8)-mediated pathways to achieve its proangiogenic effects and protect the cardiovascular system.

FRONTIERS IN PHARMACOLOGY (2021)

Article Gastroenterology & Hepatology

Epithelia-Sensory Neuron Cross Talk Underlies Cholestatic Itch Induced by Lysophosphatidylcholine

Yong Chen et al.

Summary: The study identified LPC as a novel pruritogen in cholestatic liver diseases, causing itch through epithelia-sensory neuron cross talk. This finding provides a new perspective for the treatment of itch.

GASTROENTEROLOGY (2021)

Review Oncology

Mechanical Aspects of Angiogenesis

Maibritt Kretschmer et al.

Summary: Angiogenesis is crucial for physiological and pathological processes, with the stiffness of the ECM and cell adhesion influencing endothelial cell behavior. Different stages of angiogenesis require various chemical and mechanical cues, with changes in ECM representing potential dysregulations in addition to erroneous biochemical signals during tumor growth.

CANCERS (2021)

Article Multidisciplinary Sciences

Caveolar peroxynitrite formation impairs endothelial TRPV4 channels and elevates pulmonary arterial pressure in pulmonary hypertension

Zdravka Daneva et al.

Summary: Recent studies have found that the activity of TRPV4 channels in endothelial cell caveolae is impaired in patients with pulmonary hypertension and mouse models. Up-regulation of iNOS and NOX1 enzymes leads to the formation of the oxidant molecule peroxynitrite, which targets the structural protein caveolin-1 and reduces the activity of TRPV4 channels.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Review Cardiac & Cardiovascular Systems

Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association

Abdulla A. Damluji et al.

Summary: Mechanical complications of acute myocardial infarction, such as acute mitral regurgitation and ventricular septal defect, pose significant risks to patients and require multidisciplinary collaboration for prompt diagnosis and intervention. However, due to a lack of high-quality studies guiding clinical practice, there is significant variability in care based on local expertise and available resources.

CIRCULATION (2021)

Review Biochemistry & Molecular Biology

GDF15 and Cardiac Cells: Current Concepts and New Insights

Luc Rochette et al.

Summary: GDF15, a member of the TGF-beta superfamily, is induced by injury and aging, and plays a role in inflammation and the pathogenesis of cardiovascular diseases, metabolic disorders, and neurodegenerative processes. It functions as a heart-derived endocrine hormone with cardioprotective properties, and may serve as a therapeutic target in cardiovascular diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Cardiac & Cardiovascular Systems

Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases JACC State-of-the-Art Review

Marco Giuseppe Del Buono et al.

Summary: CMD encompasses multiple pathogenetic mechanisms involving coronary micro-circulation and plays a major role in myocardial ischemia in patients with angina without obstructive coronary artery disease, as well as in various other cardiovascular conditions. Despite the lack of specific treatment, further research is needed to provide personalized therapies for this diverse group of patients.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Review Endocrinology & Metabolism

GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease

Dongdong Wang et al.

Summary: Growth differentiation factor 15 (GDF15) expression is induced by cellular stress, metformin, and exercise. Its effects on food intake and inflammation are mediated through specific receptors and signaling pathways, making it a promising target for the treatment of metabolic diseases such as obesity and diabetes.

NATURE REVIEWS ENDOCRINOLOGY (2021)

Article Pharmacology & Pharmacy

Protective Effect of Shexiang Baoxin Pill on Myocardial Ischemia/Reperfusion Injury in Patients With STEMI

Haixia Qin et al.

Summary: The study revealed that Shexiang Baoxin Pill (SBP) has a protective effect on myocardial ischemia/reperfusion injury in patients with STEMI, improving cardiac function and decreasing myocardial infarction area.

FRONTIERS IN PHARMACOLOGY (2021)

Review Pathology

Endothelial Cell Calcium Signaling during Barrier Function and Inflammation

Prarthana J. Dalal et al.

AMERICAN JOURNAL OF PATHOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Knockout of Canopy 2 activates p16INK4a pathway to impair cardiac repair

Wenjuan Yin et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)

Review Medicine, Research & Experimental

Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics

Xiaojun Feng et al.

THERANOSTICS (2019)

Review Cardiac & Cardiovascular Systems

Treatment of atherosclerosis by traditional Chinese medicine: Questions and quandaries

Chuan Wang et al.

ATHEROSCLEROSIS (2018)

Article Biochemistry & Molecular Biology

The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL

Paul J. Emmerson et al.

NATURE MEDICINE (2017)

Review Medicine, General & Internal

Acute Myocardial Infarction

Jeffrey L. Anderson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Cardiac & Cardiovascular Systems

Executive Summary: Heart Disease and Stroke Statistics-2016 Update A Report From the American Heart Association

Dariush Mozaffarian et al.

CIRCULATION (2016)

Article Integrative & Complementary Medicine

Metabolomic Strategy for Studying the Intervention and the Synergistic Effects of the Shexiang Baoxin Pill for Treating Myocardial Infarction in Rats

Li Xiang et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)

Article Cell Biology

Calmodulin is essential for angiogenesis in response to hypoxic stress in endothelial cells

Wei-Gan Shen et al.

CELL BIOLOGY INTERNATIONAL (2007)

Article Cardiac & Cardiovascular Systems

Reduced collateral circulation to the infarct-related artery in elderly patients with acute myocardial infarction

T Kurotobi et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)